close
  • Approved Use: Aimovig® is a prescription medicine used for the preventive treatment of migraine in adults.

You are now leaving aimovig.com

You are about to leave the aimovig.com website and enter a website operated by a third party. Amgen is not responsible for and does not endorse or control the content contained on this third-party website.

Continue

You are now leaving aimovig.com

You are about to leave the aimovig.com website and enter a website operated by a third party. Amgen & Novartis are not responsible for and do not endorse or control the content contained on this third-party website.

Continue
  1. Access to americanmigrainefoundation.org is not intended to provide medical advice or a referral to a particular physician;
  2. Patients should discuss with their physician their experience with the patient’s medical condition and should then determine if the physician is qualified to perform the procedure;
  3. Patients should discuss the risks and benefits of any procedure with their physician;
  4. americanmigrainefoundation.org is an independent entity, and not affiliated with, or an agent of, Amgen Inc.
  5. Amgen Inc. has not entered into any agreement with any doctor affiliated with americanmigrainefoundation.org to render any treatment or care to any patient, and has not evaluated the credentials, experience or expertise of any physician affiliated with, or referred through, americanmigrainefoundation.org.
  6. AMGEN INC. MAKES NO EXPRESS, IMPLIED OR STATUTORY WARRANTIES OR REPRESENTATIONS (INCLUDING THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE) AMERICANMIGRAINEFOUNDATION.ORG. TO THE MAXIMUM EXTENT PERMITTED BY LAW, AMGEN INC. AND ITS AFFILIATES ARE NOT RESPONSIBLE FOR AND EXPRESSLY DISCLAIM ALL LIABILITY, INCLUDING WITHOUT LIMITATION, FOR DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, AND SPECIAL OR OTHER DAMAGES ARISING FROM OR RELATED TO THE USE OF ANY SERVICES OFFERED BY AMERICANMIGRAINEFOUNDATION.ORG. BY ACCESSING AMERICANMIGRAINEFOUNDATION.ORG, YOU AGREE, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW THAT YOU WILL HOLD AMGEN INC. AND ITS AFFILIATES HARMLESS FROM ANY AND ALL CLAIMS ARISING FROM OR IN CONNECTION WITH ANY ACT OR OMISSION OF AMERICANMIGRAINEFOUNDATION.ORG.

You are now leaving aimovig.com

You are about to leave the aimovig.com website and enter a website operated by a third party. Amgen Inc. is not responsible for and does not endorse or control the content contained on this third-party website.

Click “OK” to proceed or “CANCEL” to return to aimovig.com

By clicking “OK” below, you acknowledge that you have read and reviewed the information contained within the Notice of Third-Party Site at the bottom of the page.

OK CANCEL
How to Take Aimovig
How to Take Aimovig

Aimovig is a once-monthly injection you take at home after getting instructions from your doctor.

Get all the necessary details for each dose in the Instructions for Use below. For a quick overview, see the reference guides or the video.

70-ifu-simple

70 mg/mL
Instructions for Use

140-ifu-simple

140 mg/mL
Instructions for Use

70-ref-guide-simple

70 mg/mL
Reference Guide

140-ref-guide-simple

140 mg/mL
Reference Guide

Your doctor will walk you through how to inject Aimovig, and detailed instructions are provided in the packaging—any information on this website should not replace those instructions. If you have further questions, please contact your doctor.

Know your dose

Aimovig comes in two doses: 70 mg/mL and 140 mg/mL. Each dose comes in an easy-to-use autoinjector. Ask your doctor which dose is best for you.

70-pen 140-pen
96%

of patients found the autoinjector device easy to use.*

*

Based on a study of about 200 adults with migraine who performed a simulated injection

Need-to-know info about the SureClick® autoinjector:

  • Injecting Aimovig takes about 15 seconds or less

  • The needle is hidden inside the safety guard

  • Must be stored in the refrigerator (at 36-46°F/2-8°C) in the original carton to protect it from light

  • Please don’t freeze or shake it

  • Once out of the refrigerator, it should be kept at room temperature (up to 25°C/77°F) in the original carton, and it must be used within 7 days

  • Throw it away if it’s been at room temperature for more than 7 days

  • Leave the autoinjector at room temperature for at least 30 minutes before injecting

IMPORTANT SAFETY INFORMATION

In clinical studies, the most common injection site reactions were pain, redness, and swelling.

Frequently asked questions

  • How should I store my autoinjectors?
    You should store Aimovig in the refrigerator at 36-46°F/2-8°C. Keep it in the original carton to protect the medicine from light. Don't freeze or shake the Aimovig SureClick® autoinjector. It is important to keep Aimovig out of the reach of children. When you are ready to take Aimovig, remove it from the refrigerator at least 30 minutes prior to use so it reaches room temperature. If you remove Aimovig from the refrigerator, it can be stored at room temperature (68-77°F/20-25°C) in the original carton and used within 7 days. It is important to safely throw away Aimovig right after using it or if it has been left at room temperature (68-77°F/20-25°C) for more than 7 days. Do not throw away Aimovig in your household trash. You can safely dispose of your autoinjector in an FDA-cleared sharps disposal container. See the detailed 70 mg/mL Instructions for Use or the 140 mg/mL Instructions for Use for complete information about how to take Aimovig.
  • What will happen if I press the button before I’m ready to do the injection on my skin? 
    Even when you press the start button, the injection will only happen when the safety guard is also pushed into the autoinjector See the detailed 70 mg/mL Instructions for Use or the 140 mg/mL Instructions for Use for complete information about how to take Aimovig.
  • Can I move the autoinjector around on my skin while I am choosing an injection site? 
    It’s okay to move the autoinjector around on your skin as long as you don’t press the start button. However, if you press the start button and the safety guard is pushed into the autoinjector, the injection will begin. See the detailed 70 mg/mL Instructions for Use or the 140 mg/mL Instructions for Use for complete information about how to take Aimovig.
  • Can I release the start button after I start my injection? 
    You can release the start button, but you should continue to hold the autoinjector firmly against your skin during the injection. See the detailed 70 mg/mL Instructions for Use or the 140 mg/mL Instructions for Use for complete information about how to take Aimovig.
  • Will the start button pop up after I release my thumb? 
    The start button may not pop up after you release your thumb if you have held your thumb down during the injection. That’s okay. See the detailed 70 mg/mL Instructions for Use or the 140 mg/mL Instructions for Use for complete information about how to take Aimovig. 
  • What if I don’t hear a click after pushing the device down on my skin for 15 seconds?
    If you don’t hear a click, confirm the injection is complete by checking that the window has turned yellow. See the detailed 70 mg/mL Instructions for Use or the 140 mg/mL Instructions for Use for complete information about how to take Aimovig.
  • Should I take Aimovig on the same day every month? 
    Aimovig is FDA-approved to be taken once a month, according to the Prescribing Information. Talk to your doctor about your dosing schedule. 
  • What are the most common side effects of Aimovig? 
    The most common side effects of Aimovig include pain, redness, or swelling at the injection site and constipation. Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all of the possible side effects of Aimovig. Ask your doctor or pharmacist for more information. Call your doctor for medical advice about side effects. You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 
    1-800-FDA-1088. Read this lmportant Safety Information.

Contact us here

1-833-AIMOVIG (1-833-246-6844)

8AM–9PM ET, Mon–Fri

+ +

Important Safety Information

Who should not use Aimovig®?
Do not use Aimovig if you are allergic to erenumab-aooe or any ingredients in

Who should not use Aimovig? Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®. Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

 
–

Important Safety Information

Who should not use Aimovig®? Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®. Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are pregnant or plan to become pregnant, breastfeeding or plan to breastfeed. Tell your HCP about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements. What are possible side effects of Aimovig®? Aimovig® may cause serious side effects, including:
  • Allergic reactions. Allergic reactions, including rash or swelling can happen after receiving Aimovig®. This can happen within hours to days after using Aimovig®. Call your HCP or get emergency medical help right away if you have any of the following symptoms of an allergic reaction: swelling of the face, mouth, tongue or throat, or trouble breathing.
  • Constipation with serious complications. Severe constipation can happen after receiving Aimovig®. In some cases people have been hospitalized or needed surgery. Contact your HCP if you have severe constipation or constipation associated with symptoms such as severe or constant belly pain, vomiting, swelling of belly or bloating.
  • High blood pressure. High blood pressure or worsening of high blood pressure can happen after receiving Aimovig®. Contact your healthcare provider if you have an increase in blood pressure.
The most common side effects of Aimovig® are pain, redness, or swelling at the injection site and constipation. These are not all of the possible side effects of Aimovig®. Call your HCP for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Click here for the full Prescribing Information and Patient Product Information.

Approved Use

Aimovig® is a prescription medicine used for the preventive treatment of migraine in adults.
References: 1. Parsabiv® (etelcalcetide) prescribing information, Amgen. 2. Data on file, Amgen; [Summary of Clinical Efficacy; 2015]. 3. Alexander ST, et al. Mol Pharmacol. 2015;88:853-865. 4. Data on file, Amgen; [Report R20130052, 2014]. 5. Chen P, et al. CPT Pharmacometrics Syst Pharmacol. 2016;5:484-494. 6. Sensipar® (cinacalcet) prescribing information, Amgen. 7. Ma JN, et al. J Pharmacol Exp Ther. 2011;337:275-284.